Finance

Beta
Lists
Q4 2026 earnings • released • Revenue beat +1.48%
See results
3349:TYO
Cosmos Pharmaceutical Corp
¥6,240.00
-4.78%
(-313.00) 1D
Jul 15, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 3349...
Open
¥6,576
High
¥6,590
Low
¥6,237
Mkt. cap
499.21B
Avg. vol.
381.08K
Volume
753.20K
Dividend
1.20%
Quarterly dividend
¥19
Ex-dividend date
Nov 27, 2025
P/E ratio
15.43
52-wk high
¥10,045
52-wk low
¥5,615
EPS
¥404
Shares outstanding
19.80M
No. of employees
6K
Open
¥6,576
High
¥6,590
Low
¥6,237
Mkt. cap
499.21B
Avg. vol.
381.08K
Volume
753.20K
Dividend
1.20%
Quarterly dividend
¥19
Ex-dividend date
Nov 27, 2025
P/E ratio
15.43
52-wk high
¥10,045
52-wk low
¥5,615
EPS
¥404
Shares outstanding
19.80M
No. of employees
6K
News stories
From sources across the web
About Cosmos Pharmaceutical Corp
CEO-
Employees5.71K
FoundedDec 1983
Headquarters-
SectorDrug
Websitecosmospc.co.jp
Last report
Jul 13, 2026
Fiscal period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
289.20B / 284.97B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
272.39B
264.78B
273.20B
289.20B
Cost of goods sold
215.22B
209.07B
216.15B
-
Cost of revenue
215.22B
209.07B
216.15B
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
45.64B
46.57B
45.83B
-
Operating expense
45.64B
46.57B
45.83B
-
Total operating expenses
260.86B
255.64B
261.97B
-
Operating income
11.54B
9.14B
11.23B
-
Other non operating income
627.00M
801.00M
667.00M
-
EBT including unusual items
12.09B
9.58B
11.96B
-
EBT excluding unusual items
12.08B
9.85B
11.81B
-
Income tax expense
3.92B
3.10B
3.86B
-
Effective tax rate
32.40%
32.35%
32.26%
-
Other operating expenses
-
-
-
-
Net income
8.17B
6.48B
8.10B
-
Net profit margin
3.00%
2.45%
2.96%
3.21%
Earnings per share
-
-
-
-
Interest and investment income
27.00M
19.00M
16.00M
-
Interest expense
-110.00M
-107.00M
-107.00M
-
Net interest expenses
-83.00M
-88.00M
-91.00M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
17.09B
15.00B
16.79B
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer